Literature DB >> 19543232

Induced pluripotent stem cells and the stability of the differentiated state.

Alan Colman1, Oliver Dreesen.   

Abstract

For much of the last century, the differentiated state that characterizes the many cell types of an adult organism was thought to be stable and abrogated only in rare instances by transdifferentiation, metaplasia or cancer. This stability was thought to reside in the autoregulatory molecular circuitry that exists between the cytoplasm and the nucleus, a status quo that could be disrupted during somatic cell nuclear transfer, to reprogramme cells to a pluripotent state. Pioneering work in the 1980s showed that transdifferentiation of cell lineages could be induced by the addition of transcription factors. However, these conversions were usually confined to cell types from the same germ layer, and proof of conversion was difficult to obtain. This deficiency has now been overturned by demonstrations that exogenously added transcription factors can convert differentiated cell types into embryonic-like induced pluripotent stem cells. Here, we highlight the recent progress, and the implications of this work for our understanding of the relationship between the pluripotent and more differentiated cell states.

Entities:  

Mesh:

Year:  2009        PMID: 19543232      PMCID: PMC2727431          DOI: 10.1038/embor.2009.142

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  67 in total

Review 1.  Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.

Authors:  Rudolf Jaenisch; Richard Young
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

2.  A combined chemical and genetic approach for the generation of induced pluripotent stem cells.

Authors:  Yan Shi; Jeong Tae Do; Caroline Desponts; Heung Sik Hahm; Hans R Schöler; Sheng Ding
Journal:  Cell Stem Cell       Date:  2008-06-05       Impact factor: 24.633

3.  Dissecting direct reprogramming through integrative genomic analysis.

Authors:  Tarjei S Mikkelsen; Jacob Hanna; Xiaolan Zhang; Manching Ku; Marius Wernig; Patrick Schorderet; Bradley E Bernstein; Rudolf Jaenisch; Eric S Lander; Alexander Meissner
Journal:  Nature       Date:  2008-05-28       Impact factor: 49.962

4.  Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse.

Authors:  Matthias Stadtfeld; Nimet Maherali; David T Breault; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-02-14       Impact factor: 24.633

5.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

6.  c-Myc is dispensable for direct reprogramming of mouse fibroblasts.

Authors:  Marius Wernig; Alexander Meissner; John P Cassady; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2007-12-13       Impact factor: 24.633

Review 7.  Transdifferentiation and metaplasia as a paradigm for understanding development and disease.

Authors:  D Eberhard; D Tosh
Journal:  Cell Mol Life Sci       Date:  2008-01       Impact factor: 9.261

8.  Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.

Authors:  Tobias Brambrink; Ruth Foreman; G Grant Welstead; Christopher J Lengner; Marius Wernig; Heikyung Suh; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2008-02-07       Impact factor: 24.633

9.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

10.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds.

Authors:  Danwei Huangfu; René Maehr; Wenjun Guo; Astrid Eijkelenboom; Melinda Snitow; Alice E Chen; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2008-06-22       Impact factor: 54.908

View more
  11 in total

Review 1.  Impact of induced pluripotent stem cells on the study of central nervous system disease.

Authors:  Paige E Cundiff; Stewart A Anderson
Journal:  Curr Opin Genet Dev       Date:  2011-01-27       Impact factor: 5.578

2.  Liver stem cells derived from the bone marrow and umbilical cord blood.

Authors:  Kyung Ha Ryu
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

3.  Comparison of potency between histone deacetylase inhibitors trichostatin A and valproic acid on enhancing in vitro development of porcine somatic cell nuclear transfer embryos.

Authors:  Young June Kim; Kwang Sung Ahn; Minjeong Kim; Hosup Shim
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-02-27       Impact factor: 2.416

4.  MyoD gene suppression by Oct4 is required for reprogramming in myoblasts to produce induced pluripotent stem cells.

Authors:  Shuichi Watanabe; Hiroyuki Hirai; Yoko Asakura; Christopher Tastad; Mayank Verma; Charles Keller; James R Dutton; Atsushi Asakura
Journal:  Stem Cells       Date:  2011-03       Impact factor: 6.277

5.  Biomaterial implants mediate autologous stem cell recruitment in mice.

Authors:  A Nair; J Shen; P Lotfi; C-Y Ko; C C Zhang; L Tang
Journal:  Acta Biomater       Date:  2011-07-13       Impact factor: 8.947

6.  Caenorhabditis elegans aristaless/Arx gene alr-1 restricts variable gene expression.

Authors:  Irini Topalidou; Alexander van Oudenaarden; Martin Chalfie
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-22       Impact factor: 11.205

Review 7.  Modeling neurological disorders by human induced pluripotent stem cells.

Authors:  Tanut Kunkanjanawan; Parinya Noisa; Rangsun Parnpai
Journal:  J Biomed Biotechnol       Date:  2011-11-24

8.  Suppressive effects of induced pluripotent stem cell-conditioned medium on in vitro hypertrophic scarring fibroblast activation.

Authors:  Ye Ren; Chen-Liang Deng; Wei-Dong Wan; Jiang-Hong Zheng; Guang-Yu Mao; Song-Lin Yang
Journal:  Mol Med Rep       Date:  2014-12-18       Impact factor: 2.952

9.  OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.

Authors:  Yumiko Matsubara; Yukako Ono; Hidenori Suzuki; Fumio Arai; Toshio Suda; Mitsuru Murata; Yasuo Ikeda
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

Review 10.  Recent advances in genetically modified animal models of glaucoma and their roles in drug repositioning.

Authors:  Chikako Harada; Atsuko Kimura; Xiaoli Guo; Kazuhiko Namekata; Takayuki Harada
Journal:  Br J Ophthalmol       Date:  2018-10-26       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.